Thomas Harbo
0000-0003-2178-6076
Aarhus Universitetshospital
20 papers found
Refreshing results…
A population-based follow-up study of maximal muscle strength and mobility in patients with myasthenia gravis
Reply to “Maybe myopathic EMG but not myopathy” and to “Exclude differentials before attributing post-COVID fatigue to myopathy”
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision
Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: an international observational study
Guillain–Barré syndrome in Denmark: a population-based study on epidemiology, diagnosis and clinical severity
Regional variation of Guillain-Barré syndrome.
IgPro20, the Polyneuropathy and Treatment with Hizentra® study (PATH), and the treatment of chronic inflammatory demyelinating polyradiculoneuropathy with subcutaneous IgG
Effects of centralizing acute stroke services
Subcutaneous immunoglobulin treatment in CIDP and MMN. Efficacy, treatment satisfaction and costs
International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome
[Valproate can induce reversible encephalopathy].
Subcutaneous immunoglobulin preserves muscle strength in chronic inflammatory demyelinating polyneuropathy
Hemolytic anemia following high dose intravenous immunoglobulin in patients with chronic neurological disorders
Maximal isokinetic and isometric muscle strength of major muscle groups related to age, body mass, height, and sex in 178 healthy subjects
The effect of IgG levels on the number of natural killer cells and their Fc receptors in chronic inflammatory demyelinating polyradiculoneuropathy
Long-term therapy with high doses of subcutaneous immunoglobulin in multifocal motor neuropathy
Acute motor response following a single IVIG treatment course in chronic inflammatory demyelinating polyneuropathy
Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: a randomized, single-blinded cross-over trial
Muscle performance relates to physical function and quality of life in long-term chronic inflammatory demyelinating polyradiculoneuropathy
Length-dependent weakness and electrophysiological signs of secondary axonal loss in chronic inflammatory demyelinating polyradiculoneuropathy
Missing publications? Search for publications with a matching author name.